Biogen (BIIB) Amortization - Intangibles (2009 - 2026)

Biogen has reported Amortization - Intangibles for 18 years, with the latest figure at $168.2 million in Q2 2026.

• On a quarterly basis, Amortization - Intangibles rose 28.5% year-over-year to $168.2 million in Q2 2026; TTM through Jun 2026 was $577.0 million, a 10.07% increase from a year earlier, with the FY2025 full-year figure at $515.0 million, up 15.29% from the prior year.
• Amortization - Intangibles was $168.2 million for Q2 2026 at Biogen, up from $136.5 million in the prior quarter.
• The five-year high for Amortization - Intangibles was $175.0 million in Q4 2022, with the low at $50.2 million in Q1 2023.
• Average Amortization - Intangibles over 5 years is $104.0 million, with a median of $99.4 million recorded in 2024.
• The largest YoY upside for Amortization - Intangibles was 156.98% in 2022 against a maximum downside of 88.83% in 2022.
• Over 5 years, Amortization - Intangibles stood at $175.0 million in 2022, then sank by 56.23% to $76.6 million in 2023, then jumped by 97.39% to $151.2 million in 2024, then dropped by 9.66% to $136.6 million in 2025, then climbed by 23.13% to $168.2 million in 2026.
• The last three Amortization - Intangibles figures came in at $168.2 million (Q2 2026), $136.5 million (Q1 2026), and $136.6 million (Q4 2025), per Business Quant data.